Published in Lancet on January 25, 1993
Influence of coexisting disease on survival on renal-replacement therapy. Lancet (1993) 4.12
Origin of whales from early artiodactyls: hands and feet of Eocene Protocetidae from Pakistan. Science (2001) 3.29
Nutritional status of children in Nepal, 1975. Bull World Health Organ (1976) 2.34
Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM (2002) 2.00
Integrated dialysis and renal transplantation: small is beautiful. Br Med J (1980) 1.85
Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr Biol (1996) 1.81
Prospective iterative trial of proteasome inhibitor-based desensitization. Am J Transplant (2015) 1.72
Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol Dial Transplant (2001) 1.55
Characterization of flagella genes of Agrobacterium tumefaciens, and the effect of a bald strain on virulence. Mol Microbiol (1997) 1.55
Chronic renal failure: factors influencing nephrology referral. QJM (1994) 1.54
New structural features of the flagellar base in Salmonella typhimurium revealed by rapid-freeze electron microscopy. J Bacteriol (1991) 1.51
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Urinary tract infection in old age. Br J Hosp Med (1989) 1.43
The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol (1996) 1.38
Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: fact or fiction? Lancet (1980) 1.21
Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc (2005) 1.17
The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigens. Lancet (1983) 1.15
Diurnal changes in the concentrations of plasma lipids, sugars, insulin and corticosterone in rats fed diets containing various carbohydrates. Horm Metab Res (1974) 1.13
Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant (2009) 1.11
Cyclosporine-induced fetotoxicity in the rat. Transplantation (1985) 1.10
A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol (1997) 1.08
Percutaneous transluminal angioplasty for atheromatous renal artery stenosis--blood pressure response and discriminant analysis of outcome predictors. Q J Med (1990) 1.04
Death during the first 90 days of dialysis: a case control study. Am J Kidney Dis (1995) 1.04
Fatty acid synthetase activity in the liver and adipose tissue of rats fed with various carbohydrates. Biochem J (1972) 1.03
Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int (2000) 1.02
Acute renal failure: factors influencing nephrology referral and outcome. QJM (1997) 1.01
Staphylococcal septicaemia, endocarditis, and osteomyelitis in dialysis and renal transplant patients. Postgrad Med J (1980) 1.01
Hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM (2003) 1.00
Manipulation of cytokine networks in transplantation: false hope or realistic opportunity for tolerance? Transplantation (1997) 0.99
Prolonged islet allograft acceptance in the absence of interleukin 4 expression. Transpl Immunol (1996) 0.98
Performance of stochastic approaches for forecasting river water quality. Water Res (2001) 0.97
Managing urinary tract infection. BMJ (1993) 0.95
Survival on renal replacement therapy in Europe: is there a 'centre effect'? Nephrol Dial Transplant (1996) 0.93
A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc (2005) 0.92
IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol (1998) 0.92
Association of Fc receptor-blocking antibodies and human renal transplant survival. Transplantation (1982) 0.90
Partial body neutron activation analysis in vivo: a new approach to the investigation of metabolic bone disease. Phys Med Biol (1973) 0.90
Effect of vagotomy and pyloroplasty on the interdigestive myoelectrical complex of the stomach. Gut (1972) 0.89
The native arteriovenous fistula in 2007. Surveillance and monitoring. J Nephrol (2007) 0.89
Patients' perception of health on renal replacement therapy: evaluation using a new instrument. Nephrol Dial Transplant (1995) 0.89
Allopurinol, erythema multiforme, and renal insufficiency. BMJ (1996) 0.89
Does metabolic bone disease follow truncal vagotomy and gastrojejunostomy? Br Med J (Clin Res Ed) (1983) 0.88
Possible mechanism of action of transfusion effect in renal transplantation. Lancet (1982) 0.88
Evidence-based medicine in nephrology: identifying and critically appraising the literature. Nephrol Dial Transplant (2000) 0.87
BRAVO I: A pilot study of vascular brachytherapy in polytetrafluoroethylene dialysis access grafts. Kidney Int (2006) 0.87
Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc (2002) 0.85
Passive enhancement of rat renal allografts by antibodies to a non-SD (Ag-B) locus analogous to Ia and demonstration of linkage to the MHC. Transplant Proc (1977) 0.85
Activity of lipogenic enzymes and plasma triglyceride levels in the rat and the chicken as determined by the nature of the dietary fat and dietary carbohydrate. Nutr Metab (1972) 0.84
The role of RT1 antigen differences in semi-allogeneic rat pregnancy. Clin Sci (Lond) (1987) 0.84
Diagnostic value of urinary N-acetyl-beta-D-glucosaminidase, its isoenzymes and the fractional excretion of sodium following renal transplantation. Clin Chim Acta (1983) 0.84
Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit. J Clin Virol (2006) 0.83
Evidence that protective Fc-receptor-blocking antibodies in renal transplantation are alloantibodies not autoantibodies. Transplantation (1985) 0.83
Antineutrophil cytoplasmic antibody associated vasculitis and renal failure in Behçet's disease. Nephrol Dial Transplant (1994) 0.83
I alpha-hydroxycholecalciferol: a treatment of renal bone disease. Br Med J (1975) 0.83
Long-term complications of dialysis: infection. Kidney Int Suppl (1993) 0.82
The effect of the dosage of steroids on the incidence of cytomegalovirus infections in renal transplant recipients. J Infect (1984) 0.82
Is nodular regenerative hyperplasia of the liver associated with azathioprine therapy after renal transplantation? Nephrol Dial Transplant (1988) 0.82
Acute renal failure due to continuous rifampicin. Clin Nephrol (1983) 0.82
Control of secretion of parathyroid hormone in secondary hyperparathyroidism. Clin Endocrinol (Oxf) (1982) 0.82
Language tests for EC doctors. Lancet (1992) 0.82
Proteasome inhibition reduces donor-specific antibody levels. Transplant Proc (2009) 0.82
Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C]leucine. Kidney Int (1992) 0.81
Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis. Transplant Proc (2005) 0.81
High vaginal swab(HVS), routine microscopy and culture sensitivity in diabetic and non diabetic, a comparative retrospective study of five years. Indian J Med Sci (1991) 0.81
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. Transplant Proc (1999) 0.81
Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis (1997) 0.81
Early corticosteroid withdrawal under modern immunosuppression in renal transplantation: multivariate analysis of risk factors for acute rejection. Transplant Proc (2005) 0.80
Lymphocytotoxins in sera from highly sensitized multiparous dialysis patients: antibody class, relationship with the HLA and with paternal antigens. Clin Sci (Lond) (1991) 0.79
Equity of renal replacement therapy utilization: a prospective population-based study. QJM (1999) 0.79
Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. Nephron (1985) 0.79
The effect of repeated transfusion and cyclosporine A administration on alloantibody levels in sensitized rats. Transplant Proc (1987) 0.79
Interwell tracing by environmental isotopes at Fimkassar Oilfield, Pakistan. Appl Radiat Isot (2003) 0.79
Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc (2005) 0.79
Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts. Transplantation (2000) 0.79
The effect of chromium on the hyperlipaemic action of sucrose. Nutr Metab (1971) 0.79
Sucrose induction of hepatic hyperplasia in the rat. Nature (1972) 0.79
Drug hypersensitivity causing granulomatous interstitial nephritis. Am J Kidney Dis (1988) 0.79
Proliferative glomerulonephritis with acute renal failure-a rare manifestation in seronegative rheumatoid arthritis. Mymensingh Med J (2009) 0.79
In vitro paclitaxel and radiation effects on the cell types responsible for vascular stenosis: a preliminary analysis. Blood Purif (2006) 0.78
Cyclosporin A prevents sensitization after blood transfusion in multiparous rats. Clin Sci (Lond) (1988) 0.78
Renal biopsy in the milk-alkali syndrome. J Clin Pathol (1976) 0.78
Solutions for hemodialysis vascular access dysfunction: thinking out of the box!! J Vasc Access (2006) 0.78
Glycoside primers of Psittacanthus cucullaris. J Nat Prod (1999) 0.78
Fetus as an allograft: noncytotoxic maternal antibodies to HLA-linked paternal antigens. Am J Reprod Immunol (1989) 0.78
Maternal antibodies to paternal B-lymphocytes in normal and abnormal pregnancy. Am J Reprod Immunol Microbiol (1986) 0.78
Outcomes of patients with rejection post-polyomavirus nephropathy. Transplant Proc (2005) 0.78
Post mortem studies on infertile buffalo bulls: anatomical and microbiological findings. Vet Rec (1985) 0.78
Prolonged survival of rat renal allografts after multiple allogeneic pregnancies: strain specificity and role of erythrocyte antibody rosette inhibiting antibodies. Clin Sci (Lond) (1985) 0.78
The influence of cyclosporin A on alloantibody responses in inbred rats: provisional evidence for a serum factor with antiidiotypic activity. Clin Exp Immunol (1988) 0.77
Expression of beta 1 integrins in IgA nephropathy. Nephrol Dial Transplant (1997) 0.77
Perforated duodenal ulcer treated by vagotomy and drainage. J R Coll Surg Edinb (1970) 0.77
The effect of cyclosporine on humoral and cellular alloreactivity to allogeneic pregnancy in rats. Transplantation (1986) 0.77
Measurement of hemodynamic and anatomic parameters in a swine arteriovenous fistula model. J Vasc Access (2008) 0.77
The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity. Transplant Proc (1988) 0.77
African American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Transplant Proc (2005) 0.77
The effect of dietary protein restriction on high dose gentamicin nephrotoxicity in rats. Br J Exp Pathol (1988) 0.77
The value of autologous indium (111In)-labelled platelets in the diagnosis of renal transplant rejection. Clin Nephrol (1984) 0.77
Differential expression of trophoblast lymphocyte cross-reactive (TLX) antigens on T and B lymphocytes. Am J Reprod Immunol Microbiol (1986) 0.77
ACE inhibitors in the management of haemodialysis ascites. Nephrol Dial Transplant (1994) 0.76